1. Institute of Agrobiotechnology, Centre for Research and Technology, Thessaloniki, Greece;
2. Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
3. Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;
4. Hematology Department, Nikea General Hospital, Athens, Greece;
5. HLA Tissue Typing, Immunohematology and Transfusion Medicine Service, Istituto Scientifico San Raffaele, Milan, Italy;
6. Laborary of Hematology and Université Pierre et Marie Curie, Hôpital Pitié-Salpètrière, Paris, France; and
7. Laboratory and Unit of Lymphoid Malignancies, Department of Oncology, Università Vita-Salute, San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy